Clinical Trials Sponsored by Institut Claudius Regaud

Total 122 results

Institut Claudius Regaud

Recruiting

Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae (LAMBEAU STEPA)

Head and Neck Cancer | Oropharynx Cancer | Oral Cavity Cancer

France
Institut Claudius Regaud

Recruiting

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (BLAD-RAD01)

Urothelial Bladder Cancer

France
Institut Claudius Regaud

Recruiting

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy (MINER)

Solid Cancers

France
Institut Claudius Regaud

Recruiting

Prospective Melanoma Database

Melanoma

France
Institut Claudius Regaud

Active, not recruiting

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm (COCABIO000)

Triple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mm

France
Institut Claudius Regaud

Completed

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO) (CREDO)

METASTATIC CANCER

France
Institut Claudius Regaud

Completed

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. (CARMMYC)

Breast Cancer

France
Institut Claudius Regaud

Completed

Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up. (ADHESIPH)

Metastatic Solid Tumor

France
Institut Claudius Regaud

Completed

A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. (MEDIRAD)

Differentiated Thyroid Cancer

France
Institut Claudius Regaud

Withdrawn

Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA) (PROSTIRNA)

Prostatic Cancer, Castration-Resistant

France
Institut Claudius Regaud

Unknown

Evaluation of the Adhesion to the GENEPY Network (GENEPY)

Hereditary Breast and Ovarian Cancer | Hereditary Cancer Syndrome | Hereditary Colorectal Endometrial Cancer Syndrome

France
Institut Claudius Regaud

Terminated

Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella (GRATSEC)

Breast Cancer

France
Institut Claudius Regaud

Terminated

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Soft Tissue Sarcoma of Members

France
Institut Claudius Regaud

Completed

Evaluation of the Impact of a Follow-up Phone Call Nurse Device in the Care of Patients With Chemotherapy Treatment (EVAL'COACH)

Solid Tumors

France
Institut Claudius Regaud

Completed

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer (PHACS)

Hormono-depending Adjuvant Breast Cancer

France
Institut Claudius Regaud

Completed

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

Genital Neoplasms, Male

France
Institut Claudius Regaud

Completed

Determination of Carboplatin's Optimal Plasmatic Exposure

Neoplasms

France
Institut Claudius Regaud

Completed

Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

Breast Neoplasms

France
Institut Claudius Regaud

Recruiting

Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation (GATA-2)

GATA2 Gene Mutation

France
Institut Claudius Regaud

Recruiting

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer (EUTACAM)

Breast Cancer

France
Institut Claudius Regaud

Recruiting

Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma (CHIC-STS01)

Soft Tissue Sarcoma

France
Institut Claudius Regaud

Recruiting

Deciphering Mechanisms Underlying Cancer Immunogenicity (DECIDE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Anal Cancer | Cervical Intraepithelial Neoplasia 3 | Glioblastoma Multiforme of Brain Stem

France
Institut Claudius Regaud

Recruiting

Prospective and Retrospective Breast Cancer Database

Breast Cancer

France
Institut Claudius Regaud

Active, not recruiting

A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation (SILK BM)

NSCLC

France
Institut Claudius Regaud

Active, not recruiting

Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients (IMMUSPHINX)

Melanoma

France
Institut Claudius Regaud

Active, not recruiting

Cost Utility of Radical Surgery in Ovarian Cancer (CURSOC)

Ovarian Cancer

France
Institut Claudius Regaud

Active, not recruiting

Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. (MARTA)

Breast Cancer Invasive

France
Institut Claudius Regaud

Completed

Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy (FEMINICOL)

Cervix Cancer | Vaginal Cancer

France
Institut Claudius Regaud

Terminated

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. (REVER)

HER2-positive Breast Cancer

France
Institut Claudius Regaud

Completed

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma? (SAMHY SARCOME)

Sarcoma

France
Institut Claudius Regaud

Completed

TNF in Melanoma Patients Treated With Immunotherapy (MELANFα)

Melanoma

France
Institut Claudius Regaud

Withdrawn

Evaluation of Low-Level Laser Therapy Efficacy in Pain Management of Grade 2 Oral Mucositis Induced by Radiotherapy or Chemoradiotherapy: a Study in Patients With Upper Aerodigestive Tract Cancer (ESMULLLAT)

Upper Aerodigestive Tract Neoplasms

France
Institut Claudius Regaud

Completed

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin (CMTpostopFDOPA)

Medullary Thyroid Cancer

France
Institut Claudius Regaud

Completed

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer (IQversusMI)

Cancer

France
Institut Claudius Regaud

Terminated

Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma (SPECTRO GLIO)

Glioblastoma

France
Institut Claudius Regaud

Completed

Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). (MOTIVATE)

Solid Tumor

France
Institut Claudius Regaud

Completed

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma (IPIAP-STM)

Soft Tissue Sarcoma

France
Institut Claudius Regaud

Withdrawn

Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy (GIRAFE)

Head and Neck Cancer

France
Institut Claudius Regaud

Completed

Evaluation of Pain and Postoperative Nausea Vomiting Incidence in Outpatient Surgery at IUCT-Oncopole Hospital

Cancer | Surgery | Anesthesia

France
Institut Claudius Regaud

Completed

Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study (STEMRI)

Glioblastoma

France
Institut Claudius Regaud

Completed

Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer (PITCA)

Breast Cancer

France
Institut Claudius Regaud

Completed

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer (MIRHO)

Breast Cancer

France
Institut Claudius Regaud

Unknown

From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers (BREASTEROL)

Breast Cancer

France
Institut Claudius Regaud

Terminated

Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer (SPI COHERENCE)

Non Small Cell Lung Cancer | Lung Nodule

France
Institut Claudius Regaud

Completed

Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not (OXYTAM)

Breast Cancer

France
Institut Claudius Regaud

Recruiting

A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. (HYPOSARC)

Soft Tissue Sarcoma

France
Institut Claudius Regaud

Recruiting

Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene. (LUCID)

DDX41 Gene Mutation

France
Institut Claudius Regaud

Recruiting

Impact of Circadian Rhythm on the Spread of Circulating Tumor Cells in Lung Cancer Patients (SLEEP_CTC)

Lung Cancer

France
Institut Claudius Regaud

Recruiting

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

ORL Cancer

France
Institut Claudius Regaud

Recruiting

Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain. (TEC-ORL)

Head and Neck Cancer

France

3

Subscribe